TS

the SRIW Life Sciences

North America, Wisconsin, United States, Belgium

Description

the SRIW Life Sciences

Investor Profile

the SRIW Life Sciences has made 3 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series B (67%)
  • Series A (33%)

Country Focus

  • Belgium (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Biopharma
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does the SRIW Life Sciences frequently co-invest with?

New Science Ventures
North America, Connecticut, United States, Greenwich
Co-Investments: 2
IB
Europe, Berlin, Germany, Berlin
Co-Investments: 1
Seventure Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
CL
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 2
Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 2
Vives Louvain Technology Fund
Europe, Vlaams-Brabant, Belgium, Louvain-la-neuve
Co-Investments: 2
Investsud
Europe, Luxembourg, Belgium, Marche-en-famenne
Co-Investments: 2
N
Europe, Vlaams-Brabant, Belgium, Louvain-la-neuve
Co-Investments: 1

Which angels does the SRIW Life Sciences often collaborate with?

OV
Europe, Belgium
Shared Deals: 1
PD
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 2

What are some of recent deals done by the SRIW Life Sciences?

Novadip Biosciences

Mont-saint-guibert, Brabant Wallon, Belgium

Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.

BiotechnologyHealth CareMedicalTherapeutics
Series BNov 3, 2022
Amount Raised: $23,398,518
Novadip Biosciences

Mont-saint-guibert, Brabant Wallon, Belgium

Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.

BiotechnologyHealth CareMedicalTherapeutics
Series BOct 28, 2021
Amount Raised: $22,196,495
A-Mansia Biotech

Louvain-la-neuve, Vlaams-Brabant, Belgium

A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium.

BiopharmaBiotechnologyLife Science
Series AApr 27, 2018
Amount Raised: $15,790,497